保钾利尿剂对心力衰竭患者肾素-血管紧张素-醛固酮系统及钾潴留的影响
Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure.
作者信息
Nicholls M G, Espiner E A, Hughes H, Rogers T
出版信息
Br Heart J. 1976 Oct;38(10):1025-30. doi: 10.1136/hrt.38.10.1025.
Abstract
The renin-angiotensin-aldosterone system and electrolyte levels in 11 patients with heart failure controlled on digoxin and frusemide were investigated after separate periods of Slow K, spironolactone, and amiloride therapy. When spironolactone or amiloride replaced Slow K, distinct parallel increments in the levels of renin, angiotensin II, and aldosterone resulted. Though plasma potassium was generally higher after spironolactone and amiloride than after Slow K, exchangeable potassium was similar with the three regimens. There was no significant relation between plasma potassium and concurrent exchangeable potassium.
摘要
在分别进行慢钾、螺内酯和氨氯吡咪治疗的不同阶段后，对11例用地高辛和速尿控制心力衰竭的患者的肾素 - 血管紧张素 - 醛固酮系统及电解质水平进行了研究。当螺内酯或氨氯吡咪替代慢钾时，肾素、血管紧张素II和醛固酮水平出现明显的平行升高。虽然螺内酯和氨氯吡咪治疗后的血浆钾一般高于慢钾治疗后，但三种治疗方案的可交换钾相似。血浆钾与同时期的可交换钾之间无显著关系。
相似文献
1
Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure.保钾利尿剂对心力衰竭患者肾素-血管紧张素-醛固酮系统及钾潴留的影响
Br Heart J. 1976 Oct;38(10):1025-30. doi: 10.1136/hrt.38.10.1025.
2
Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.高血压、醛固酮增多且血浆肾素水平低的患者手术与长期螺内酯治疗的比较
Br Med J. 1972 Jun 24;2(5816):729-34. doi: 10.1136/bmj.2.5816.729.
3
Plasma renin in congestive heart failure in man.人类充血性心力衰竭中的血浆肾素
Med J Aust. 1970 Jan 31;1(5):215-7. doi: 10.5694/j.1326-5377.1970.tb77814.x.
4
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.未经治疗的心力衰竭：引入利尿剂后的临床及神经内分泌效应
Br Heart J. 1987 Jan;57(1):17-22. doi: 10.1136/hrt.57.1.17.
5
Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.阿米洛利与氢氯噻嗪联合治疗对高血压患者血浆及全身钾、血压和肾素-血管紧张素-醛固酮系统的影响。
Eur J Clin Pharmacol. 1986;30(2):151-6. doi: 10.1007/BF00614293.
6
Amiloride. A potassium-sparing natriuretic agent.氨氯吡咪。一种保钾利尿钠药。
Circulation. 1968 Jan;37(1):45-53. doi: 10.1161/01.cir.37.1.45.
7
Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure.充血性心力衰竭患者对急性和慢性速尿治疗的血流动力学及激素反应
Clin Sci (Lond). 1980 Dec;59(6):443-9. doi: 10.1042/cs0590443.
8
The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.螺内酯、氨氯吡咪、氯沙坦与噻嗪类药物（SALT）对低肾素性高血压和醛固酮-肾素比值升高患者的双盲交叉试验。
Circulation. 2007 Jul 17;116(3):268-75. doi: 10.1161/CIRCULATIONAHA.107.690396. Epub 2007 Jul 2.
9
Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.氨氯吡咪、螺内酯及氯化钾用于噻嗪类药物治疗的高血压患者
Clin Pharmacol Ther. 1980 Apr;27(4):533-43. doi: 10.1038/clpt.1980.75.
10
Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.氨氯吡咪和螺内酯对呋塞米作用下动脉高血压患者基础状态和治疗期肾小管功能及中心血压的影响：一项双盲、随机、安慰剂对照交叉试验。
Clin Exp Hypertens. 2013;35(5):313-24. doi: 10.3109/10641963.2012.721843. Epub 2012 Sep 11.
引用本文的文献
1
The acute effects of amiloride and potassium canrenoate on digoxin-induced positive inotropism in healthy volunteers.氨氯吡咪和钾螺内酯对健康志愿者地高辛诱导的正性肌力作用的急性影响。
Eur J Clin Pharmacol. 1993;45(2):195-6. doi: 10.1007/BF00315506.
2
Spironolactone in thiazide-induced hypokalaemia: variable response between patients.螺内酯治疗噻嗪类药物所致低钾血症：患者间反应各异。
Br J Clin Pharmacol. 1981 Feb;11(2):153-8. doi: 10.1111/j.1365-2125.1981.tb01119.x.
3
Diuretic induced hypokalaemia: relationship to dosage interval and plasma aldosterone.利尿剂诱发的低钾血症：与给药间隔及血浆醛固酮的关系
Br J Clin Pharmacol. 1982 Sep;14(3):449-52. doi: 10.1111/j.1365-2125.1982.tb02007.x.
4
Hyponatraemia in congestive heart failure during treatment with captopril.卡托普利治疗充血性心力衰竭期间的低钠血症
Br Med J. 1980 Oct 4;281(6245):909. doi: 10.1136/bmj.281.6245.909.
5
Enalapril in heart failure.依那普利治疗心力衰竭
Br J Clin Pharmacol. 1984;18 Suppl 2(Suppl 2):163S-167S. doi: 10.1111/j.1365-2125.1984.tb02594.x.
6
Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease.轻度高血压和缺血性心脏病患者中利尿剂诱发的低钾血症的致心律失常潜力。
Br Heart J. 1985 Sep;54(3):290-7. doi: 10.1136/hrt.54.3.290.
7
Diuretics and potassium in the elderly.老年人的利尿剂与钾
J R Coll Physicians Lond. 1987 Apr;21(2):148-52.
8
Amiloride enhances the secretion but not the synthesis of renin in renal juxtaglomerular cells.氨氯吡咪可增强肾近球旁细胞中肾素的分泌，但不影响其合成。
Pflugers Arch. 1991 Aug;419(1):32-7. doi: 10.1007/BF00373744.
9
Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade.血压正常男性的充血性心力衰竭。血流动力学、肾素及血管紧张素II阻断
Br Heart J. 1978 Oct;40(10):1134-42. doi: 10.1136/hrt.40.10.1134.
10
The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure.钾补充剂、螺内酯或氨氯地平对心力衰竭患者钾状态的影响。
Postgrad Med J. 1978 Jun;54(632):405-9. doi: 10.1136/pgmj.54.632.405.
Zotero 插件